Korlym — Cigna
Endogenous Cushing’s syndrome with type 2 diabetes mellitus or glucose intolerance in adults who have failed surgery or are not candidates for surgery
Preferred products
- generic mifepristone tablets
Initial criteria
- Patient meets the standard Cushing’s – Mifepristone Prior Authorization Policy criteria; AND
- Patient has tried generic mifepristone tablets; AND
- Patient cannot continue to use generic mifepristone tablets due to a formulation difference in the inactive ingredient(s) [e.g., difference in dyes, fillers, preservatives] which, per the prescriber, would result in a significant allergy or serious adverse reaction [documentation required]
Approval duration
1 year